{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:05:28Z","timestamp":1793858728746,"version":"4.6.1"},"reference-count":210,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41571-026-01149-8","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:50:21Z","timestamp":1777373421000},"page":"569-581","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Emerging trends in the global burden of colorectal cancer"],"prefix":"10.1038","volume":"23","author":[{"given":"David J.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8093-1531","authenticated-orcid":false,"given":"Bhawna","family":"Sirohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9835-7662","authenticated-orcid":false,"given":"Yin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-6767","authenticated-orcid":false,"given":"Andrew T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"1149_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1149_CR2","unstructured":"International Agency for Research on Cancer. Global Cancer Observatory: Cancer Today. https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/900-world-fact-sheet.pdf (2026)."},{"key":"1149_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1470-2045(24)00600-4","volume":"26","author":"H Sung","year":"2025","unstructured":"Sung, H. et al. Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data. Lancet Oncol. 26, 51\u201363 (2025).","journal-title":"Lancet Oncol."},{"key":"1149_CR4","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1136\/gutjnl-2019-319511","volume":"68","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L. et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut 68, 2179\u20132185 (2019).","journal-title":"Gut"},{"key":"1149_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan, E. et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72, 338\u2013344 (2023).","journal-title":"Gut"},{"key":"1149_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S2468-1253(22)00044-9","volume":"7","author":"GBD 2019 Colorectal Cancer Collaborators","year":"2022","unstructured":"GBD 2019 Colorectal Cancer Collaborators. Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol. Hepatol. 7, 627\u2013647 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1149_CR7","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/ijc.33715","volume":"149","author":"C Gullickson","year":"2021","unstructured":"Gullickson, C. et al. Colorectal cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index: a population-based registry study. Int. J. Cancer 149, 1553\u20131563 (2021).","journal-title":"Int. J. Cancer"},{"key":"1149_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-60449-0","volume":"14","author":"AAG Dantas","year":"2024","unstructured":"Dantas, A. A. G. et al. Multilevel analysis of social determinants of advanced stage colorectal cancer diagnosis. Sci. Rep. 14, 9667 (2024).","journal-title":"Sci. Rep."},{"key":"1149_CR9","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.cgh.2024.11.019","volume":"23","author":"L Guo","year":"2025","unstructured":"Guo, L. et al. Global distribution of colorectal cancer staging at diagnosis: an evidence synthesis. Clin. Gastroenterol. Hepatol.\u00a023, 2088\u20132101 (2025).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1149_CR10","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1053\/j.gastro.2023.06.033","volume":"165","author":"RB Issaka","year":"2023","unstructured":"Issaka, R. B., Chan, A. T. & Gupta, S. AGA clinical practice update on risk stratification for colorectal cancer screening and post-polypectomy surveillance: expert review. Gastroenterology 165, 1280\u20131291 (2023).","journal-title":"Gastroenterology"},{"key":"1149_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12876-025-03948-2","volume":"25","author":"X Zhang","year":"2025","unstructured":"Zhang, X. et al. Global burden of colon and rectal cancer and attributable risk factors in 204 countries and territories from 1990 to 2021. BMC Gastroenterol. 25, 332 (2025).","journal-title":"BMC Gastroenterol."},{"key":"1149_CR12","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel, R. L. et al. Colorectal cancer statistics, 2026. CA Cancer J. Clin. 76, e70067 (2026).","journal-title":"CA Cancer J. Clin."},{"key":"1149_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.cgh.2023.11.040","volume":"22","author":"S Gupta","year":"2024","unstructured":"Gupta, S., May, F. P., Kupfer, S. S. & Murphy, C. C. Birth cohort colorectal cancer (CRC): implications for research and practice. Clin. Gastroenterol. Hepatol. 22, 455\u2013469 (2024).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1149_CR14","doi-asserted-by":"publisher","first-page":"djw322","DOI":"10.1093\/jnci\/djw322","volume":"109","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L. et al. Colorectal cancer incidence patterns in the United States, 1974-2013. J. Natl Cancer Inst. 109, djw322 (2017).","journal-title":"J. Natl Cancer Inst."},{"key":"1149_CR15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S2468-1253(19)30147-5","volume":"4","author":"M Araghi","year":"2019","unstructured":"Araghi, M. et al. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol. Hepatol. 4, 511\u2013518 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1149_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1158\/1055-9965.EPI-18-0523","volume":"28","author":"E Feletto","year":"2019","unstructured":"Feletto, E. et al. Trends in colon and rectal cancer incidence in Australia from 1982 to 2014: analysis of data on over 375,000 cases. Cancer Epidemiol. Biomarkers Prev. 28, 83\u201390 (2019).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1149_CR17","doi-asserted-by":"publisher","first-page":"1466159","DOI":"10.3389\/fonc.2024.1466159","volume":"14","author":"T Zhang","year":"2024","unstructured":"Zhang, T. et al. Global, regional, and national trends in colorectal cancer burden from 1990 to 2021 and projections to 2040. Front. Oncol. 14, 1466159 (2024).","journal-title":"Front. Oncol."},{"key":"1149_CR18","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(25)01635-6","volume":"406","author":"GBD 2023 Cancer Collaborators","year":"2025","unstructured":"GBD 2023 Cancer Collaborators. The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet 406, 1565\u20131586 (2025).","journal-title":"Lancet"},{"key":"1149_CR19","unstructured":"Institute for Health Metrics and Evaluation. GBD Cancer Compare Data Visualization. https:\/\/vizhub.healthdata.org\/gbd-compare\/cancer (2026)."},{"key":"1149_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-03867-9","volume":"23","author":"Y Meng","year":"2025","unstructured":"Meng, Y. et al. Global, regional, and national burden of early-onset colorectal cancer from 1990 to 2021: a systematic analysis based on the global burden of disease study 2021. BMC Med. 23, 34 (2025).","journal-title":"BMC Med."},{"key":"1149_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1046\/j.1463-1318.2003.00467.x","volume":"5","author":"Y Niv","year":"2003","unstructured":"Niv, Y. Screening the average risk population for colorectal cancer: the Israeli experience 1985-97. Colorectal Dis. 5, 358\u2013361 (2003).","journal-title":"Colorectal Dis."},{"key":"1149_CR22","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/cncr.35097","volume":"130","author":"EE Half","year":"2024","unstructured":"Half, E. E. et al. Colorectal cancer screening at age 45 years in Israel: cost-effectiveness and global implications. Cancer 130, 901\u2013912 (2024).","journal-title":"Cancer"},{"key":"1149_CR23","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.7314\/APJCP.2013.14.11.6459","volume":"14","author":"M Suh","year":"2013","unstructured":"Suh, M., Choi, K. S., Lee, Y. Y., Park, B. & Jun, J. K. Cancer screening in Korea, 2012: results from the Korean National Cancer Screening Survey. Asian Pac. J. Cancer Prev. 14, 6459\u20136463 (2013).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"1149_CR24","doi-asserted-by":"publisher","first-page":"910","DOI":"10.4143\/crt.2022.1432","volume":"55","author":"B Park","year":"2023","unstructured":"Park, B. et al. Overview of the national cancer screening program for colorectal cancer in Korea over 14 years (2004-2017). Cancer Res. Treat. 55, 910\u2013917 (2023).","journal-title":"Cancer Res. Treat."},{"key":"1149_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/cncr.29715","volume":"122","author":"T Okada","year":"2016","unstructured":"Okada, T. et al. International collaboration between Japan and Chile to improve detection rates in colorectal cancer screening. Cancer 122, 71\u201377 (2016).","journal-title":"Cancer"},{"key":"1149_CR26","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1177\/0969141306013001S03","volume":"13","author":"H Saito","year":"2006","unstructured":"Saito, H. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan. J. Med. Screen. 13, S6\u2013S7 (2006).","journal-title":"J. Med. Screen."},{"key":"1149_CR27","unstructured":"Basu P. et al. International Agency for Research on Cancer. Cancer Screening in Five Continents. https:\/\/canscreen5.iarc.fr (2025)."},{"key":"1149_CR28","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1016\/j.canep.2016.03.010","volume":"44","author":"MS Sierra","year":"2016","unstructured":"Sierra, M. S. & Forman, D. Burden of colorectal cancer in Central and South America. Cancer Epidemiol. 44, S74\u2013S81 (2016).","journal-title":"Cancer Epidemiol."},{"key":"1149_CR29","doi-asserted-by":"publisher","first-page":"102371","DOI":"10.1016\/j.canep.2023.102371","volume":"84","author":"SV Gopalani","year":"2023","unstructured":"Gopalani, S. V. et al. Breast, cervical, and colorectal cancer screening test use in the US territories of Guam, Puerto Rico, and the US Virgin Islands. Cancer Epidemiol. 84, 102371 (2023).","journal-title":"Cancer Epidemiol."},{"key":"1149_CR30","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ijc.34950","volume":"155","author":"I Mosquera","year":"2024","unstructured":"Mosquera, I. et al. Assessment of barriers to cancer screening and interventions implemented to overcome these barriers in 27 Latin American and Caribbean countries. Int. J. Cancer 155, 719\u2013730 (2024).","journal-title":"Int. J. Cancer"},{"key":"1149_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2022-002158","volume":"12","author":"V Irazola","year":"2023","unstructured":"Irazola, V. et al. Quality improvement intervention to increase colorectal cancer screening at the primary care setting: a cluster-randomised controlled trial. BMJ Open Qual. 12, e002158 (2023).","journal-title":"BMJ Open Qual."},{"key":"1149_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58920-z","volume":"14","author":"G Alfaro","year":"2024","unstructured":"Alfaro, G., Berger, Z., Mondschein, S., Subiabre, F. & Yankovic, N. Barriers to the use of tests for early detection of colorectal cancer in Chile. Sci. Rep. 14, 8817 (2024).","journal-title":"Sci. Rep."},{"key":"1149_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03225-8","volume":"11","author":"H Saito","year":"2021","unstructured":"Saito, H. et al. The long term participation trend for the colorectal cancer screening after the 2011 triple disaster in Minamisoma City, Fukushima, Japan. Sci. Rep. 11, 23851 (2021).","journal-title":"Sci. Rep."},{"key":"1149_CR34","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1017\/S1368980019004737","volume":"24","author":"G Cediel","year":"2021","unstructured":"Cediel, G. et al. Ultra-processed foods drive to unhealthy diets: evidence from Chile. Public Health Nutr. 24, 1698\u20131707 (2021).","journal-title":"Public Health Nutr."},{"key":"1149_CR35","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3390\/nu11071605","volume":"11","author":"G G\u00f3mez","year":"2019","unstructured":"G\u00f3mez, G. et al. Diet quality and diet diversity in eight Latin American countries: results from the Latin American Study of Nutrition and Health (ELANS). Nutrients 11, 1605 (2019).","journal-title":"Nutrients"},{"key":"1149_CR36","unstructured":"GBD 2021 Adult BMI Collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet 405, 813\u2013838 (2025)."},{"key":"1149_CR37","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980024002027","volume":"27","author":"Y Sakai","year":"2024","unstructured":"Sakai, Y., Rahayu, Y. Y. S., Zhao, Y. & Araki, T. Dietary pattern transition and its nutrient intakes and diet quality among Japanese population: results from the 2003-2019 National Survey. Public Health Nutr. 27, e231 (2024).","journal-title":"Public Health Nutr."},{"key":"1149_CR38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/PPO.0b013e318237e408","volume":"17","author":"F Kastrinos","year":"2011","unstructured":"Kastrinos, F. & Syngal, S. Inherited colorectal cancer syndromes. Cancer J. 17, 405\u2013415 (2011).","journal-title":"Cancer J."},{"key":"1149_CR39","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1053\/j.gastro.2018.08.017","volume":"155","author":"D Leddin","year":"2018","unstructured":"Leddin, D. et al. Clinical practice guideline on screening for colorectal cancer in individuals with a family history of nonhereditary colorectal cancer or adenoma: the Canadian Association of Gastroenterology Banff Consensus. Gastroenterology 155, 1325\u20131347 (2018).","journal-title":"Gastroenterology"},{"key":"1149_CR40","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1016\/j.cgh.2019.09.007","volume":"17","author":"VH Roos","year":"2019","unstructured":"Roos, V. H. et al. Effects of family history on relative and absolute risks for colorectal cancer: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 17, 2657\u20132667 (2019).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1149_CR41","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/ajg.2016.52","volume":"111","author":"MCS Wong","year":"2016","unstructured":"Wong, M. C. S. et al. Risk of colorectal neoplasia in individuals with self-reported family history: a prospective colonoscopy study from 16 Asia-Pacific regions. Am. J. Gastroenterol. 111, 1621\u20131629 (2016).","journal-title":"Am. J. Gastroenterol."},{"key":"1149_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44487-8","volume":"13","author":"MH Keivanlou","year":"2023","unstructured":"Keivanlou, M. H. et al. Family history of cancer as a potential risk factor for colorectal cancer in EMRO countries: a systematic review and meta-analysis. Sci. Rep. 13, 17457 (2023).","journal-title":"Sci. Rep."},{"key":"1149_CR43","doi-asserted-by":"publisher","first-page":"8633","DOI":"10.3390\/ijerph18168633","volume":"18","author":"MDP Ram\u00edrez-D\u00edaz","year":"2021","unstructured":"Ram\u00edrez-D\u00edaz, M. D. P., Alvarez-Ba\u00f1uelos, M. T., Robaina-Castellanos, M. S., Castro-Enr\u00edquez, P. P. & Guzm\u00e1n-Garc\u00eda, R. E. Association of family history and life habits in the development of colorectal cancer: a matched case-control study in Mexico. Int. J. Environ. Res. Public Health 18, 8633 (2021).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"1149_CR44","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.cgh.2012.04.015","volume":"10","author":"L Lathroum","year":"2012","unstructured":"Lathroum, L., Ramos-Mercado, F., Hernandez-Marrero, J., Villafa\u00f1a, M. & Cruz-Correa, M. Ethnic and sex disparities in colorectal neoplasia among Hispanic patients undergoing screening colonoscopy. Clin. Gastroenterol. Hepatol. 10, 997\u20131001 (2012).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1149_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/CEJ.0000000000000439","volume":"28","author":"L Katsidzira","year":"2019","unstructured":"Katsidzira, L. et al. A case-control study of risk factors for colorectal cancer in an African population. Eur. J. Cancer Prev. 28, 145\u2013150 (2019).","journal-title":"Eur. J. Cancer Prev."},{"key":"1149_CR46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12876-024-03385-7","volume":"24","author":"NN Tazinkeng","year":"2024","unstructured":"Tazinkeng, N. N. et al. Incidence and risk factors for colorectal cancer in Africa: a systematic review and meta-analysis. BMC Gastroenterol. 24, 303 (2024).","journal-title":"BMC Gastroenterol."},{"key":"1149_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224023","volume":"14","author":"L Katsidzira","year":"2019","unstructured":"Katsidzira, L. et al. Investigation on the hereditary basis of colorectal cancers in an African population with frequent early onset cases. PLoS ONE 14, e0224023 (2019).","journal-title":"PLoS ONE"},{"key":"1149_CR48","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1200\/JCO.2016.71.0012","volume":"35","author":"MB Yurgelun","year":"2017","unstructured":"Yurgelun, M. B. et al. Cancer susceptibility gene mutations in individuals with colorectal cancer. J. Clin. Oncol. 35, 1086\u20131095 (2017).","journal-title":"J. Clin. Oncol."},{"key":"1149_CR49","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1093\/jnci\/djab124","volume":"113","author":"A Cercek","year":"2021","unstructured":"Cercek, A. et al. A comprehensive comparison of early-onset and average-onset colorectal cancers. J. Natl Cancer Inst. 113, 1683\u20131692 (2021).","journal-title":"J. Natl Cancer Inst."},{"key":"1149_CR50","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1053\/j.gastro.2017.11.004","volume":"154","author":"EM Stoffel","year":"2018","unstructured":"Stoffel, E. M. et al. Germline genetic features of young individuals with colorectal cancer. Gastroenterology 154, 897\u2013905 (2018).","journal-title":"Gastroenterology"},{"key":"1149_CR51","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jamaoncol.2016.5194","volume":"3","author":"R Pearlman","year":"2017","unstructured":"Pearlman, R. et al. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 3, 464\u2013471 (2017).","journal-title":"JAMA Oncol."},{"key":"1149_CR52","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1200\/JCO.2015.61.4503","volume":"33","author":"ME Mork","year":"2015","unstructured":"Mork, M. E. et al. High prevalence of hereditary cancer syndromes in adolescents and young adults with colorectal cancer. J. Clin. Oncol. 33, 3544\u20133549 (2015).","journal-title":"J. Clin. Oncol."},{"key":"1149_CR53","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1053\/j.gastro.2015.07.036","volume":"149","author":"JH Rubenstein","year":"2015","unstructured":"Rubenstein, J. H., Enns, R., Heidelbaugh, J. & Barkun, A. American Gastroenterological Association Institute guideline on the diagnosis and management of Lynch syndrome. Gastroenterology 149, 777\u2013782 (2015).","journal-title":"Gastroenterology"},{"key":"1149_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52562-5","volume":"16","author":"J Park","year":"2025","unstructured":"Park, J. et al. Impact of population screening for Lynch syndrome insights from the All of Us data. Nat. Commun. 16, 523 (2025).","journal-title":"Nat. Commun."},{"key":"1149_CR55","doi-asserted-by":"crossref","unstructured":"International Mismatch Repair Consortium. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study. Lancet Oncol. 22, 1014\u20131022 (2021).","DOI":"10.1016\/S1470-2045(21)00189-3"},{"key":"1149_CR56","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1158\/1055-9965.EPI-16-0693","volume":"26","author":"AK Win","year":"2017","unstructured":"Win, A. K. et al. Prevalence and penetrance of major genes and polygenes for colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 26, 404\u2013412 (2017).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1149_CR57","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ajg.2014.435","volume":"110","author":"S Syngal","year":"2015","unstructured":"Syngal, S. et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am. J. Gastroenterol. 110, 223\u2013263 (2015).","journal-title":"Am. J. Gastroenterol."},{"key":"1149_CR58","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.gie.2020.01.028","volume":"91","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in familial adenomatous polyposis syndromes. Gastrointest. Endosc. 91, 963\u2013982 (2020).","journal-title":"Gastrointest. Endosc."},{"key":"1149_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14755","volume":"8","author":"S Haraldsdottir","year":"2017","unstructured":"Haraldsdottir, S. et al. Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2. Nat. Commun. 8, 14755 (2017).","journal-title":"Nat. Commun."},{"key":"1149_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3599-4","volume":"17","author":"BM Rossi","year":"2017","unstructured":"Rossi, B. M. et al. A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America. BMC Cancer 17, 623 (2017).","journal-title":"BMC Cancer"},{"key":"1149_CR61","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.3892\/or.2016.5060","volume":"36","author":"K Lagerstedt-Robinson","year":"2016","unstructured":"Lagerstedt-Robinson, K. et al. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population. Oncol. Rep. 36, 2823\u20132835 (2016).","journal-title":"Oncol. Rep."},{"key":"1149_CR62","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1053\/j.gastro.2015.07.052","volume":"149","author":"RSC Guindalini","year":"2015","unstructured":"Guindalini, R. S. C. et al. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Gastroenterology 149, 1446\u20131453 (2015).","journal-title":"Gastroenterology"},{"key":"1149_CR63","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1200\/PO.20.00290","volume":"4","author":"RE Rosenblum","year":"2020","unstructured":"Rosenblum, R. E. et al. Lynch syndrome-associated variants and cancer rates in an ancestrally diverse biobank. JCO Precis. Oncol.\u00a04, 1429\u20131444\u00a0(2020).","journal-title":"JCO Precis. Oncol."},{"key":"1149_CR64","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejca.2019.11.004","volume":"125","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Variants of DNA mismatch repair genes derived from 33,998 Chinese individuals with and without cancer reveal their highly ethnic-specific nature. Eur. J. Cancer 125, 12\u201321 (2020).","journal-title":"Eur. J. Cancer"},{"key":"1149_CR65","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.gim.2022.01.014","volume":"24","author":"N Abu-Ghazaleh","year":"2022","unstructured":"Abu-Ghazaleh, N., Kaushik, V., Gorelik, A., Jenkins, M. & Macrae, F. Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: systematic review and meta-analysis. Genet. Med. 24, 971\u2013985 (2022).","journal-title":"Genet. Med."},{"key":"1149_CR66","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1001\/jama.2011.743","volume":"305","author":"V Bonadona","year":"2011","unstructured":"Bonadona, V. et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 305, 2304\u20132310 (2011).","journal-title":"JAMA"},{"key":"1149_CR67","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41588-022-01222-9","volume":"55","author":"C Fernandez-Rozadilla","year":"2023","unstructured":"Fernandez-Rozadilla, C. et al. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. Nat. Genet. 55, 89\u201399 (2023).","journal-title":"Nat. Genet."},{"key":"1149_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47399-x","volume":"15","author":"Z Chen","year":"2024","unstructured":"Chen, Z. et al. Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes. Nat. Commun. 15, 3557 (2024).","journal-title":"Nat. Commun."},{"key":"1149_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41819-0","volume":"14","author":"M Thomas","year":"2023","unstructured":"Thomas, M. et al. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations. Nat. Commun. 14, 6147 (2023).","journal-title":"Nat. Commun."},{"key":"1149_CR70","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1053\/j.gastro.2010.07.038","volume":"139","author":"SS Kupfer","year":"2010","unstructured":"Kupfer, S. S. et al. Genetic heterogeneity in colorectal cancer associations between African and European americans. Gastroenterology 139, 1677\u20131685 (2010).","journal-title":"Gastroenterology"},{"key":"1149_CR71","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/ijc.32664","volume":"146","author":"K Weigl","year":"2020","unstructured":"Weigl, K., Chang-Claude, J., Hsu, L., Hoffmeister, M. & Brenner, H. Establishing a valid approach for estimating familial risk of cancer explained by common genetic variants. Int. J. Cancer 146, 68\u201375 (2020).","journal-title":"Int. J. Cancer"},{"key":"1149_CR72","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.ajhg.2022.10.009","volume":"109","author":"N Mars","year":"2022","unstructured":"Mars, N. et al. Systematic comparison of family history and polygenic risk across 24 common diseases. Am. J. Hum. Genet. 109, 2152\u20132162 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"1149_CR73","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ajhg.2020.07.006","volume":"107","author":"M Thomas","year":"2020","unstructured":"Thomas, M. et al. Genome-wide modeling of polygenic risk score in colorectal cancer risk. Am. J. Hum. Genet. 107, 432\u2013444 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"1149_CR74","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1053\/j.gastro.2019.12.012","volume":"158","author":"AN Archambault","year":"2020","unstructured":"Archambault, A. N. et al. Cumulative burden of colorectal cancer-associated genetic variants is more strongly associated with early-onset vs late-onset cancer. Gastroenterology 158, 1274\u20131286 (2020).","journal-title":"Gastroenterology"},{"key":"1149_CR75","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","volume":"400","author":"GBD 2019 Cancer Risk Factors Collaborators","year":"2022","unstructured":"GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 400, 563\u2013591 (2022).","journal-title":"Lancet"},{"key":"1149_CR76","doi-asserted-by":"publisher","first-page":"519","DOI":"10.4321\/S1130-01082011001000004","volume":"103","author":"LM B\u00e9jar","year":"2011","unstructured":"B\u00e9jar, L. M., Gili, M., Infantes, B. & Marcott, P. F. Effects of changes in dietary habits on colorectal cancer incidence in twenty countries from four continents during the period 1971-2002. Rev. Esp. Enferm. Dig. 103, 519\u2013529 (2011).","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"1149_CR77","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet 403, 1027\u20131050 (2024).","journal-title":"Lancet"},{"key":"1149_CR78","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1002\/ijc.30686","volume":"140","author":"MM Fidler","year":"2017","unstructured":"Fidler, M. M., Bray, F., Vaccarella, S. & Soerjomataram, I. Assessing global transitions in human development and colorectal cancer incidence. Int. J. Cancer 140, 2709\u20132715 (2017).","journal-title":"Int. J. Cancer"},{"key":"1149_CR79","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1017\/S1368980009005680","volume":"12","author":"AM Thow","year":"2009","unstructured":"Thow, A. M. Trade liberalisation and the nutrition transition: mapping the pathways for public health nutritionists. Public Health Nutr. 12, 2150\u20132158 (2009).","journal-title":"Public Health Nutr."},{"key":"1149_CR80","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s43016-023-00852-4","volume":"4","author":"M Springmann","year":"2023","unstructured":"Springmann, M., Kennard, H., Dalin, C. & Freund, F. International food trade contributes to dietary risks and mortality at global, regional and national levels. Nat. Food 4, 886\u2013893 (2023).","journal-title":"Nat. Food"},{"key":"1149_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11140-6","volume":"23","author":"M Lamminm\u00e4ki","year":"2023","unstructured":"Lamminm\u00e4ki, M. et al. A population-based cohort study on changes in breast, lung and colorectal cancer incidence and mortality among non-Western immigrant women. BMC Cancer 23, 665 (2023).","journal-title":"BMC Cancer"},{"key":"1149_CR82","doi-asserted-by":"publisher","first-page":"E122","DOI":"10.1002\/ijc.27334","volume":"131","author":"SM Mousavi","year":"2012","unstructured":"Mousavi, S. M., Fallah, M., Sundquist, K. & Hemminki, K. Age- and time-dependent changes in cancer incidence among immigrants to Sweden: colorectal, lung, breast and prostate cancers. Int. J. Cancer 131, E122\u2013E128 (2012).","journal-title":"Int. J. Cancer"},{"key":"1149_CR83","doi-asserted-by":"publisher","first-page":"648","DOI":"10.5694\/j.1326-5377.2010.tb04093.x","volume":"193","author":"GA Kune","year":"2010","unstructured":"Kune, G. A. The Melbourne Colorectal Cancer Study: reflections on a 30-year experience. Med. J. Aust. 193, 648\u2013652 (2010).","journal-title":"Med. J. Aust."},{"key":"1149_CR84","doi-asserted-by":"publisher","first-page":"113591","DOI":"10.1016\/j.socscimed.2020.113591","volume":"269","author":"WMJ Van Hemelrijck","year":"2021","unstructured":"Van Hemelrijck, W. M. J., Rosskamp, M., De Schutter, H., Verdoodt, F. & Vanthomme, K. Cancer risk among individuals of migrant origin in Belgium during the 2000s - evidence of migration as a \u201ccancer risk transition\u201d? Soc. Sci. Med. 269, 113591 (2021).","journal-title":"Soc. Sci. Med."},{"key":"1149_CR85","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1207\/S15327914NC4502_01","volume":"45","author":"KR Monroe","year":"2003","unstructured":"Monroe, K. R. et al. Correlation of dietary intake and colorectal cancer incidence among Mexican-American migrants: the multiethnic cohort study. Nutr. Cancer 45, 133\u2013147 (2003).","journal-title":"Nutr. Cancer"},{"key":"1149_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4444-0","volume":"18","author":"J Shuldiner","year":"2018","unstructured":"Shuldiner, J., Liu, Y. & Lofters, A. Incidence of breast and colorectal cancer among immigrants in Ontario, Canada: a retrospective cohort study from 2004-2014. BMC Cancer 18, 537 (2018).","journal-title":"BMC Cancer"},{"key":"1149_CR87","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12876-017-0642-5","volume":"17","author":"L Paszat","year":"2017","unstructured":"Paszat, L. et al. Risk of colorectal cancer among immigrants to Ontario, Canada. BMC Gastroenterol. 17, 85 (2017).","journal-title":"BMC Gastroenterol."},{"key":"1149_CR88","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/ije\/15.4.483","volume":"15","author":"S Kune","year":"1986","unstructured":"Kune, S., Kune, G. A. & Watson, L. The Melbourne colorectal cancer study: incidence findings by age, sex, site, migrants and religion. Int. J. Epidemiol. 15, 483\u2013493 (1986).","journal-title":"Int. J. Epidemiol."},{"key":"1149_CR89","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research. Diet, Nutrition, Physical Activity and Colorectal Cancer. https:\/\/www.wcrf.org\/wp-content\/uploads\/2024\/10\/Colorectal-cancer-report.pdf (2018)."},{"key":"1149_CR90","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/jn\/nxz268","volume":"150","author":"SK Clinton","year":"2020","unstructured":"Clinton, S. K., Giovannucci, E. L. & Hursting, S. D. The World Cancer Research Fund\/American Institute for Cancer Research third expert report on diet, nutrition, physical activity, and cancer: impact and future directions. J. Nutr. 150, 663\u2013671 (2020).","journal-title":"J. Nutr."},{"key":"1149_CR91","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1136\/gutjnl-2020-323450","volume":"70","author":"J Hur","year":"2021","unstructured":"Hur, J. et al. Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women. Gut 70, 2330\u20132336 (2021).","journal-title":"Gut"},{"key":"1149_CR92","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/j.gastro.2021.03.028","volume":"161","author":"HK Joh","year":"2021","unstructured":"Joh, H. K. et al. Simple sugar and sugar-sweetened beverage intake during adolescence and risk of colorectal cancer precursors. Gastroenterology 161, 128\u2013142 (2021).","journal-title":"Gastroenterology"},{"key":"1149_CR93","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.canep.2018.11.002","volume":"58","author":"T Tomi\u0107","year":"2019","unstructured":"Tomi\u0107, T., Dom\u00ednguez-L\u00f3pez, S. & Barrios-Rodr\u00edguez, R. Non-aspirin non-steroidal anti-inflammatory drugs in prevention of colorectal cancer in people aged 40 or older: a systematic review and meta-analysis. Cancer Epidemiol. 58, 52\u201362 (2019).","journal-title":"Cancer Epidemiol."},{"key":"1149_CR94","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cgh.2021.02.014","volume":"19","author":"PS Liang","year":"2021","unstructured":"Liang, P. S., Shaukat, A. & Crockett, S. D. AGA clinical practice update on chemoprevention for colorectal neoplasia: expert review. Clin. Gastroenterol. Hepatol. 19, 1327\u20131336 (2021).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1149_CR95","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","volume":"376","author":"PM Rothwell","year":"2010","unstructured":"Rothwell, P. M. et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376, 1741\u20131750 (2010).","journal-title":"Lancet"},{"key":"1149_CR96","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1158\/1055-9965.EPI-08-0596","volume":"18","author":"JR Johnson","year":"2009","unstructured":"Johnson, J. R. et al. Menopausal hormone therapy and risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 18, 196\u2013203 (2009).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"1149_CR97","unstructured":"National Comprehensive Cancer Network. Colorectal Cancer Screening. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=2&id=1429 (2025)."},{"key":"1149_CR98","unstructured":"National Comprehensive Cancer Network. Genetic\/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=2&id=1544 (2026)."},{"key":"1149_CR99","unstructured":"Cancer Council Australia Colorectal Cancer Screening Working Party. Clinical Practice Guidelines for the Prevention, Early Detection, and Management of Colorectal Cancer: Population Screening. https:\/\/files.magicapp.org\/guideline\/01c06572-c58e-4936-becb-ff45c842a7a0\/published_guideline_9299-2_3.pdf (2025)."},{"key":"1149_CR100","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00041433-200202000-00002","volume":"13","author":"FB Hu","year":"2002","unstructured":"Hu, F. B. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr. Opin. Lipidol. 13, 3\u20139 (2002).","journal-title":"Curr. Opin. Lipidol."},{"key":"1149_CR101","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ajcnut.2025.02.021","volume":"121","author":"AH Chu","year":"2025","unstructured":"Chu, A. H. et al. Dietary patterns and colorectal cancer risk: Global Cancer Update Programme (CUP Global) systematic literature review. Am. J. Clin. Nutr. 121, 999\u20131016 (2025).","journal-title":"Am. J. Clin. Nutr."},{"key":"1149_CR102","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1001\/jamaoncol.2017.4844","volume":"4","author":"FK Tabung","year":"2018","unstructured":"Tabung, F. K. et al. Association of dietary inflammatory potential with colorectal cancer risk in men and women. JAMA Oncol. 4, 366\u2013373 (2018).","journal-title":"JAMA Oncol."},{"key":"1149_CR103","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/ajcn\/nqy093","volume":"108","author":"FK Tabung","year":"2018","unstructured":"Tabung, F. K. et al. Association of dietary insulinemic potential and colorectal cancer risk in men and women. Am. J. Clin. Nutr. 108, 363\u2013370 (2018).","journal-title":"Am. J. Clin. Nutr."},{"key":"1149_CR104","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.annonc.2021.03.200","volume":"32","author":"Y Yue","year":"2021","unstructured":"Yue, Y. et al. Prospective evaluation of dietary and lifestyle pattern indices with risk of colorectal cancer in a cohort of younger women. Ann. Oncol. 32, 778\u2013786 (2021).","journal-title":"Ann. Oncol."},{"key":"1149_CR105","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3390\/cancers15061756","volume":"15","author":"Q Jin","year":"2023","unstructured":"Jin, Q. et al. Hyperinsulinemic and pro-inflammatory dietary patterns and metabolomic profiles are associated with increased risk of total and site-specific cancers among postmenopausal women. Cancers 15, 1756 (2023).","journal-title":"Cancers"},{"key":"1149_CR106","doi-asserted-by":"publisher","first-page":"pkaa009","DOI":"10.1093\/jncics\/pkaa009","volume":"4","author":"DA Byrd","year":"2020","unstructured":"Byrd, D. A. et al. Associations of novel dietary and lifestyle inflammation scores with incident colorectal cancer in the NIH-AARP Diet and Health Study. JNCI Cancer Spectr. 4, pkaa009 (2020).","journal-title":"JNCI Cancer Spectr."},{"key":"1149_CR107","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ajcnut.2025.01.014","volume":"121","author":"AH Chu","year":"2025","unstructured":"Chu, A. H. et al. Dietary-lifestyle patterns and colorectal cancer risk: Global Cancer Update Programme (CUP Global) systematic literature review. Am. J. Clin. Nutr. 121, 986\u2013998 (2025).","journal-title":"Am. J. Clin. Nutr."},{"key":"1149_CR108","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1053\/j.gastro.2019.06.048","volume":"158","author":"M Song","year":"2020","unstructured":"Song, M., Chan, A. T. & Sun, J. Influence of the gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterology 158, 322\u2013340 (2020).","journal-title":"Gastroenterology"},{"key":"1149_CR109","doi-asserted-by":"publisher","first-page":"13501","DOI":"10.3390\/ijms241713501","volume":"24","author":"F Celiberto","year":"2023","unstructured":"Celiberto, F. et al. Fibres and colorectal cancer: clinical and molecular evidence. Int. J. Mol. Sci. 24, 13501 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1149_CR110","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1158\/1078-0432.CCR-13-2483","volume":"20","author":"SJ Bultman","year":"2014","unstructured":"Bultman, S. J. Molecular pathways: gene-environment interactions regulating dietary fiber induction of proliferation and apoptosis via butyrate for cancer prevention. Clin. Cancer Res. 20, 799\u2013803 (2014).","journal-title":"Clin. Cancer Res."},{"key":"1149_CR111","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1136\/gutjnl-2020-322670","volume":"70","author":"LA Bolte","year":"2021","unstructured":"Bolte, L. A. et al. Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome. Gut 70, 1287\u20131298 (2021).","journal-title":"Gut"},{"key":"1149_CR112","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1001\/jama.2025.2191","volume":"333","author":"E Fernandez","year":"2025","unstructured":"Fernandez, E., Wargo, J. A. & Helmink, B. A. The microbiome and cancer: a translational science review. JAMA 333, 2188\u20132196 (2025).","journal-title":"JAMA"},{"key":"1149_CR113","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1053\/j.gastro.2021.07.008","volume":"161","author":"LH Nguyen","year":"2021","unstructured":"Nguyen, L. H. et al. The sulfur microbial diet is associated with increased risk of early-onset colorectal cancer precursors. Gastroenterology 161, 1423\u20131432 (2021).","journal-title":"Gastroenterology"},{"key":"1149_CR114","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia, W., Xie, G. & Jia, W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat. Rev. Gastroenterol. Hepatol. 15, 111\u2013128 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1149_CR115","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41575-018-0025-6","volume":"15","author":"PD Cani","year":"2018","unstructured":"Cani, P. D. & Jordan, B. F. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer. Nat. Rev. Gastroenterol. Hepatol. 15, 671\u2013682 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1149_CR116","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41586-024-07182-w","volume":"628","author":"M Zepeda-Rivera","year":"2024","unstructured":"Zepeda-Rivera, M. et al. A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche. Nature 628, 424\u2013432 (2024).","journal-title":"Nature"},{"key":"1149_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-020-01526-z","volume":"9","author":"AI Janati","year":"2020","unstructured":"Janati, A. I., Karp, I., Laprise, C., Sabri, H. & Emami, E. Detection of Fusobaterium nucleatum in feces and colorectal mucosa as a risk factor for colorectal cancer: a systematic review and meta-analysis. Syst. Rev. 9, 276 (2020).","journal-title":"Syst. Rev."},{"key":"1149_CR118","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1158\/0008-5472.CAN-13-1865","volume":"74","author":"T Tahara","year":"2014","unstructured":"Tahara, T. et al. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res. 74, 1311\u20131318 (2014).","journal-title":"Cancer Res."},{"key":"1149_CR119","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195\u2013206 (2013).","journal-title":"Cell Host Microbe"},{"key":"1149_CR120","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.gastro.2016.11.018","volume":"152","author":"Y Yang","year":"2017","unstructured":"Yang, Y. et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-\u03baB, and up-regulating expression of microRNA-21. Gastroenterology 152, 851\u2013866 (2017).","journal-title":"Gastroenterology"},{"key":"1149_CR121","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1158\/1078-0432.CCR-20-4009","volume":"27","author":"J Borowsky","year":"2021","unstructured":"Borowsky, J. et al. Association of Fusobacterium nucleatum with specific T-cell subsets in the colorectal carcinoma microenvironment. Clin. Cancer Res. 27, 2816\u20132826 (2021).","journal-title":"Clin. Cancer Res."},{"key":"1149_CR122","doi-asserted-by":"publisher","first-page":"100850","DOI":"10.1016\/j.neo.2022.100850","volume":"35","author":"Y Gao","year":"2023","unstructured":"Gao, Y. et al. Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer. Neoplasia 35, 100850 (2023).","journal-title":"Neoplasia"},{"key":"1149_CR123","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur, C. et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42, 344\u2013355 (2015).","journal-title":"Immunity"},{"key":"1149_CR124","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","volume":"580","author":"C Pleguezuelos-Manzano","year":"2020","unstructured":"Pleguezuelos-Manzano, C. et al. Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli. Nature 580, 269\u2013273 (2020).","journal-title":"Nature"},{"key":"1149_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43329-5","volume":"14","author":"B Chen","year":"2023","unstructured":"Chen, B. et al. Contribution of pks+ E. coli mutations to colorectal carcinogenesis. Nat. Commun. 14, 7827 (2023).","journal-title":"Nat. Commun."},{"key":"1149_CR126","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41586-025-09025-8","volume":"643","author":"M D\u00edaz-Gay","year":"2025","unstructured":"D\u00edaz-Gay, M. et al. Geographic and age variations in mutational processes in colorectal cancer. Nature 643, 230\u2013240 (2025).","journal-title":"Nature"},{"key":"1149_CR127","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1038\/s41591-025-03693-9","volume":"31","author":"G Piccinno","year":"2025","unstructured":"Piccinno, G. et al. Pooled analysis of 3,741 stool metagenomes from 18 cohorts for cross-stage and strain-level reproducible microbial biomarkers of colorectal cancer. Nat. Med. 31, 2416\u20132429 (2025).","journal-title":"Nat. Med."},{"key":"1149_CR128","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1053\/j.gastro.2021.02.020","volume":"160","author":"W Liu","year":"2021","unstructured":"Liu, W. et al. Microbial community heterogeneity within colorectal neoplasia and its correlation with colorectal carcinogenesis. Gastroenterology 160, 2395\u20132408 (2021).","journal-title":"Gastroenterology"},{"key":"1149_CR129","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41591-019-0458-7","volume":"25","author":"S Yachida","year":"2019","unstructured":"Yachida, S. et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat. Med. 25, 968\u2013976 (2019).","journal-title":"Nat. Med."},{"key":"1149_CR130","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12876-022-02382-y","volume":"22","author":"D Suga","year":"2022","unstructured":"Suga, D. et al. The gut microbiota composition in patients with right- and left-sided colorectal cancer and after curative colectomy, as analyzed by 16S rRNA gene amplicon sequencing. BMC Gastroenterol. 22, 313 (2022).","journal-title":"BMC Gastroenterol."},{"key":"1149_CR131","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41591-024-02963-2","volume":"30","author":"RY Tito","year":"2024","unstructured":"Tito, R. Y. et al. Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development. Nat. Med. 30, 1339\u20131348 (2024).","journal-title":"Nat. Med."},{"key":"1149_CR132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001536","volume":"20","author":"RJ Abdill","year":"2022","unstructured":"Abdill, R. J., Adamowicz, E. M. & Blekhman, R. Public human microbiome data are dominated by highly developed countries. PLoS Biol. 20, e3001536 (2022).","journal-title":"PLoS Biol."},{"key":"1149_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46265-0","volume":"15","author":"MC Ramaboli","year":"2024","unstructured":"Ramaboli, M. C. et al. Diet changes due to urbanization in South Africa are linked to microbiome and metabolome signatures of Westernization and colorectal cancer. Nat. Commun. 15, 3379 (2024).","journal-title":"Nat. Commun."},{"key":"1149_CR134","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41586-024-08485-8","volume":"638","author":"DG Maghini","year":"2025","unstructured":"Maghini, D. G. et al. Expanding the human gut microbiome atlas of Africa. Nature 638, 718\u2013728 (2025).","journal-title":"Nature"},{"key":"1149_CR135","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1053\/j.gastro.2018.04.018","volume":"155","author":"G Nakatsu","year":"2018","unstructured":"Nakatsu, G. et al. Alterations in enteric virome are associated with colorectal cancer and survival outcomes. Gastroenterology 155, 529\u2013541 (2018).","journal-title":"Gastroenterology"},{"key":"1149_CR136","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41579-021-00536-5","volume":"19","author":"G Liang","year":"2021","unstructured":"Liang, G. & Bushman, F. D. The human virome: assembly, composition and host interactions. Nat. Rev. Microbiol. 19, 514\u2013527 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"1149_CR137","doi-asserted-by":"publisher","first-page":"2257291","DOI":"10.1080\/19490976.2023.2257291","volume":"15","author":"S Luo","year":"2023","unstructured":"Luo, S. et al. Gut virome profiling identifies an association between temperate phages and colorectal cancer promoted by Helicobacter pylori infection. Gut Microbes 15, 2257291 (2023).","journal-title":"Gut Microbes"},{"key":"1149_CR138","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1053\/j.gastro.2022.06.038","volume":"163","author":"Y Lin","year":"2022","unstructured":"Lin, Y. et al. Altered mycobiota signatures and enriched pathogenic Aspergillus rambellii are associated with colorectal cancer based on multicohort fecal metagenomic analyses. Gastroenterology 163, 908\u2013921 (2022).","journal-title":"Gastroenterology"},{"key":"1149_CR139","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1053\/j.gastro.2020.06.042","volume":"159","author":"OO Coker","year":"2020","unstructured":"Coker, O. O., Wu, W. K. K., Wong, S. H., Sung, J. J. Y. & Yu, J. Altered gut archaea composition and interaction with bacteria are associated with colorectal cancer. Gastroenterology 159, 1459\u20131470.e5 (2020).","journal-title":"Gastroenterology"},{"key":"1149_CR140","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1053\/j.gastro.2024.10.023","volume":"168","author":"T Li","year":"2025","unstructured":"Li, T. et al. Multi-cohort analysis reveals altered archaea in colorectal cancer fecal samples across populations. Gastroenterology 168, 525\u2013538 (2025).","journal-title":"Gastroenterology"},{"key":"1149_CR141","unstructured":"National Institutes of Health. Human Virome Program. https:\/\/commonfund.nih.gov\/humanvirome (2026)."},{"key":"1149_CR142","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1056\/NEJMra2300476","volume":"390","author":"TJ Woodruff","year":"2024","unstructured":"Woodruff, T. J. Health effects of fossil fuel-derived endocrine disruptors. N. Engl. J. Med. 390, 922\u2013933 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1149_CR143","doi-asserted-by":"publisher","first-page":"120442","DOI":"10.1016\/j.envpol.2022.120442","volume":"315","author":"YS Jung","year":"2022","unstructured":"Jung, Y. S. et al. Characterization and regulation of microplastic pollution for protecting planetary and human health. Environ. Pollut. 315, 120442 (2022).","journal-title":"Environ. Pollut."},{"key":"1149_CR144","doi-asserted-by":"publisher","first-page":"120916","DOI":"10.1016\/j.envres.2025.120916","volume":"270","author":"JC Botelho","year":"2025","unstructured":"Botelho, J. C., Kato, K., Wong, L. Y. & Calafat, A. M. Per- and polyfluoroalkyl substances (PFAS) exposure in the U.S. population: NHANES 1999-March 2020. Environ. Res. 270, 120916 (2025).","journal-title":"Environ. Res."},{"key":"1149_CR145","doi-asserted-by":"publisher","first-page":"115663","DOI":"10.1016\/j.ecoenv.2023.115663","volume":"267","author":"SY Wee","year":"2023","unstructured":"Wee, S. Y. & Aris, A. Z. Environmental impacts, exposure pathways, and health effects of PFOA and PFOS. Ecotoxicol. Environ. Saf. 267, 115663 (2023).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"1149_CR146","doi-asserted-by":"publisher","first-page":"151003","DOI":"10.1016\/j.scitotenv.2021.151003","volume":"809","author":"S Kurwadkar","year":"2022","unstructured":"Kurwadkar, S. et al. Per- and polyfluoroalkyl substances in water and wastewater: a critical review of their global occurrence and distribution. Sci. Total Environ. 809, 151003 (2022).","journal-title":"Sci. Total Environ."},{"key":"1149_CR147","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/ieam.4678","volume":"19","author":"RM Sorensen","year":"2023","unstructured":"Sorensen, R. M., Kanwar, R. S. & Jovanovi, B. Past, present, and possible future policies on plastic use in the United States, particularly microplastics and nanoplastics: a review. Integr. Environ. Assess. Manag. 19, 474\u2013488 (2023).","journal-title":"Integr. Environ. Assess. Manag."},{"key":"1149_CR148","doi-asserted-by":"publisher","first-page":"22843","DOI":"10.1021\/acs.est.3c09524","volume":"58","author":"N Chartres","year":"2024","unstructured":"Chartres, N. et al. Effects of microplastic exposure on human digestive, reproductive, and respiratory health: a rapid systematic review. Environ. Sci. Technol. 58, 22843\u201322864 (2024).","journal-title":"Environ. Sci. Technol."},{"key":"1149_CR149","unstructured":"International Agency for Research on Cancer. Agents Classified by the IARC Monographs, Volumes 1\u2013141. https:\/\/monographs.iarc.who.int\/agents-classified-by-the-iarc (2025)."},{"key":"1149_CR150","unstructured":"International Agency for Research on Cancer. Report of the Advisory Group to Recommend Priorities for the IARC Monographs During 2025\u20132029. https:\/\/monographs.iarc.who.int\/wp-content\/uploads\/2024\/11\/AGP_Report_2025-2029.pdf (2024)."},{"key":"1149_CR151","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/oemed-2024-109707","volume":"81","author":"M Koehoorn","year":"2025","unstructured":"Koehoorn, M. et al. Occupational asbestos exposure and gastrointestinal cancers: systematic review and meta-analyses. Occup. Environ. Med. 81, 639\u2013646 (2025).","journal-title":"Occup. Environ. Med."},{"key":"1149_CR152","doi-asserted-by":"publisher","first-page":"119213","DOI":"10.1016\/j.envres.2024.119213","volume":"257","author":"M Sassano","year":"2024","unstructured":"Sassano, M., Seyyedsalehi, M. S. & Boffetta, P. Occupational benzene exposure and colorectal cancer: a systematic review and meta-analysis. Environ. Res. 257, 119213 (2024).","journal-title":"Environ. Res."},{"key":"1149_CR153","doi-asserted-by":"publisher","first-page":"123530","DOI":"10.1016\/j.envpol.2024.123530","volume":"345","author":"PP Xie","year":"2024","unstructured":"Xie, P. P., Zong, Z. Q., Qiao, J. C., Li, Z. Y. & Hu, C. Y. Exposure to pesticides and risk of colorectal cancer: a systematic review and meta-analysis. Environ. Pollut. 345, 123530 (2024).","journal-title":"Environ. Pollut."},{"key":"1149_CR154","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-050611","volume":"11","author":"J Duijster","year":"2021","unstructured":"Duijster, J., Mughini-Gras, L., Neefjes, J. & Franz, E. Occupational exposure and risk of colon cancer: a nationwide registry study with emphasis on occupational exposure to zoonotic gastrointestinal pathogens. BMJ Open 11, e050611 (2021).","journal-title":"BMJ Open"},{"key":"1149_CR155","doi-asserted-by":"publisher","first-page":"139099","DOI":"10.1016\/j.jhazmat.2025.139099","volume":"495","author":"J Xu","year":"2025","unstructured":"Xu, J., Qu, J., Jin, H. & Mao, W. Associations between microplastics in human feces and colorectal cancer risk. J. Hazard. Mater. 495, 139099 (2025).","journal-title":"J. Hazard. Mater."},{"key":"1149_CR156","doi-asserted-by":"publisher","first-page":"16130","DOI":"10.1038\/s41598-025-98268-6","volume":"15","author":"W Pan","year":"2025","unstructured":"Pan, W. et al. Identification and analysis of microplastics in peritumoral and tumor tissues of colorectal cancer. Sci. Rep. 15, 16130 (2025).","journal-title":"Sci. Rep."},{"key":"1149_CR157","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1210\/er.2011-1050","volume":"33","author":"LN Vandenberg","year":"2012","unstructured":"Vandenberg, L. N. et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr. Rev. 33, 378\u2013455 (2012).","journal-title":"Endocr. Rev."},{"key":"1149_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25840-9","volume":"12","author":"X Hu","year":"2021","unstructured":"Hu, X. et al. A scalable workflow to characterize the human exposome. Nat. Commun. 12, 5575 (2021).","journal-title":"Nat. Commun."},{"key":"1149_CR159","doi-asserted-by":"publisher","first-page":"109787","DOI":"10.1016\/j.envres.2020.109787","volume":"188","author":"NF Fern\u00e1ndez-Mart\u00ednez","year":"2020","unstructured":"Fern\u00e1ndez-Mart\u00ednez, N. F. et al. Relationship between exposure to mixtures of persistent, bioaccumulative, and toxic chemicals and cancer risk: a systematic review. Environ. Res. 188, 109787 (2020).","journal-title":"Environ. Res."},{"key":"1149_CR160","doi-asserted-by":"publisher","first-page":"158362","DOI":"10.1016\/j.scitotenv.2022.158362","volume":"852","author":"J Li","year":"2022","unstructured":"Li, J. et al. Per- and polyfluoroalkyl substances exposure and its influence on the intestinal barrier: an overview on the advances. Sci. Total Environ. 852, 158362 (2022).","journal-title":"Sci. Total Environ."},{"key":"1149_CR161","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semcancer.2018.11.002","volume":"57","author":"KM Humphrey","year":"2019","unstructured":"Humphrey, K. M. et al. Establishing a role for environmental toxicant exposure induced epigenetic remodeling in malignant transformation. Semin. Cancer Biol. 57, 86\u201394 (2019).","journal-title":"Semin. Cancer Biol."},{"key":"1149_CR162","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.chemosphere.2019.03.096","volume":"226","author":"J Hu","year":"2019","unstructured":"Hu, J. & Yu, Y. Epigenetic response profiles into environmental epigenotoxicant screening and health risk assessment: a critical review. Chemosphere 226, 259\u2013272 (2019).","journal-title":"Chemosphere"},{"key":"1149_CR163","doi-asserted-by":"publisher","first-page":"109561","DOI":"10.1016\/j.envres.2020.109561","volume":"186","author":"FM Peinado","year":"2020","unstructured":"Peinado, F. M., Artacho-Cord\u00f3n, F., Barrios-Rodr\u00edguez, R. & Arrebola, J. P. Influence of polychlorinated biphenyls and organochlorine pesticides on the inflammatory milieu. A systematic review of in vitro, in vivo and epidemiological studies. Environ. Res. 186, 109561 (2020).","journal-title":"Environ. Res."},{"key":"1149_CR164","doi-asserted-by":"publisher","first-page":"S232","DOI":"10.1093\/carcin\/bgv038","volume":"36","author":"PA Thompson","year":"2015","unstructured":"Thompson, P. A. et al. Environmental immune disruptors, inflammation and cancer risk. Carcinogenesis 36, S232\u2013S253 (2015).","journal-title":"Carcinogenesis"},{"key":"1149_CR165","unstructured":"United Nations, Department of Economic and Social Affairs. World Urbanization Prospects 2018. https:\/\/population.un.org\/wup\/assets\/WUP2018-Report.pdf (2019)."},{"key":"1149_CR166","unstructured":"Kundu D., Debnath T., Chakravorty S., Sharma P. & Kar B. The urban century: trends and patterns of urbanisation in Asia and Africa. National Institute of Urban Affairs. https:\/\/www.centreforsustainablecities.ac.uk\/wp-content\/uploads\/2023\/02\/The-Urban-Century.pdf (2025)."},{"key":"1149_CR167","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2021.5746","volume":"325","author":"AB Knudsen","year":"2021","unstructured":"Knudsen, A. B. et al. Colorectal cancer screening: an updated modeling study for the US Preventive Services Task Force. JAMA 325, 1998\u20132011 (2021).","journal-title":"JAMA"},{"key":"1149_CR168","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.2021.6238","volume":"325","author":"KW Davidson","year":"2021","unstructured":"Davidson, K. W. et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 325, 1965\u20131977 (2021).","journal-title":"JAMA"},{"key":"1149_CR169","doi-asserted-by":"publisher","first-page":"57","DOI":"10.14309\/ajg.0000000000001548","volume":"117","author":"SG Patel","year":"2022","unstructured":"Patel, S. G. et al. Updates on age to start and stop colorectal cancer screening: recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer. Am. J. Gastroenterol. 117, 57\u201369 (2022).","journal-title":"Am. J. Gastroenterol."},{"key":"1149_CR170","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1053\/j.gastro.2021.02.015","volume":"160","author":"M Sehgal","year":"2021","unstructured":"Sehgal, M. et al. Colorectal cancer incidence after colonoscopy at ages 45-49 or 50-54 years. Gastroenterology 160, 2018\u20132028 (2021).","journal-title":"Gastroenterology"},{"key":"1149_CR171","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1001\/jamaoncol.2022.0883","volume":"8","author":"W Ma","year":"2022","unstructured":"Ma, W. et al. Age at initiation of lower gastrointestinal endoscopy and colorectal cancer risk among US women. JAMA Oncol. 8, 986\u2013993 (2022).","journal-title":"JAMA Oncol."},{"key":"1149_CR172","doi-asserted-by":"publisher","first-page":"100136","DOI":"10.1016\/j.esmogo.2025.100136","volume":"7","author":"JB Lew","year":"2025","unstructured":"Lew, J. B. et al. Re-evaluating population-level screening recommendations to address increasing early-onset colorectal cancer rates in Australia: a modelling study. ESMO Gastrointest. Oncol. 7, 100136 (2025).","journal-title":"ESMO Gastrointest. Oncol."},{"key":"1149_CR173","doi-asserted-by":"publisher","first-page":"E313","DOI":"10.1503\/cjs.000825","volume":"68","author":"SL Skulsky","year":"2025","unstructured":"Skulsky, S. L. et al. Canadian considerations on updating the age of initiation for colorectal cancer screening in individuals at average risk. Can. J. Surg. 68, E313\u2013E324 (2025).","journal-title":"Can. J. Surg."},{"key":"1149_CR174","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1001\/jamaoncol.2023.2312","volume":"9","author":"A Kalyta","year":"2023","unstructured":"Kalyta, A. et al. Association of reducing the recommended colorectal cancer screening age with cancer incidence, mortality, and costs in Canada using OncoSim. JAMA Oncol. 9, 1432\u20131436 (2023).","journal-title":"JAMA Oncol."},{"key":"1149_CR175","unstructured":"Health Promotion Administration, Ministry of Health and Welfare. Healthy Taiwan: Expanding Colorectal Cancer Screening for Better Protection. https:\/\/www.hpa.gov.tw\/EngPages\/Detail.aspx?nodeid=1051&pid=18910 (2025)."},{"key":"1149_CR176","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08809-1","volume":"21","author":"D Schliemann","year":"2021","unstructured":"Schliemann, D. et al. The implementation of colorectal cancer screening interventions in low-and middle-income countries: a scoping review. BMC Cancer 21, 1125 (2021).","journal-title":"BMC Cancer"},{"key":"1149_CR177","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.54256","volume":"7","author":"EE Montalvan-Sanchez","year":"2024","unstructured":"Montalvan-Sanchez, E. E. et al. Colorectal cancer screening programs in Latin America: a systematic review and meta-analysis. JAMA Netw. Open 7, e2354256 (2024).","journal-title":"JAMA Netw. Open"},{"key":"1149_CR178","doi-asserted-by":"publisher","first-page":"e1012","DOI":"10.1016\/S2214-109X(22)00121-8","volume":"10","author":"OI Alatise","year":"2022","unstructured":"Alatise, O. I. et al. Colorectal cancer screening with fecal immunochemical testing: a community-based, cross-sectional study in average-risk individuals in Nigeria. Lancet Glob. Health 10, e1012\u2013e1022 (2022).","journal-title":"Lancet Glob. Health"},{"key":"1149_CR179","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMoa2304714","volume":"390","author":"DC Chung","year":"2024","unstructured":"Chung, D. C. et al. A cell-free DNA blood-based test for colorectal cancer screening. N. Engl. J. Med. 390, 973\u2013983 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1149_CR180","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.2025.7515","volume":"334","author":"A Shaukat","year":"2025","unstructured":"Shaukat, A. et al. Clinical validation of a circulating tumor DNA-based blood test to screen for colorectal cancer. JAMA 334, 56\u201363 (2025).","journal-title":"JAMA"},{"key":"1149_CR181","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-23065-9","volume":"25","author":"ML Katz","year":"2025","unstructured":"Katz, M. L., Loomans-Kropp, H. A. & Reiter, P. L. Colorectal cancer screening blood test: awareness and willingness among a national sample of adults post-Federal and Drug Administration approval. BMC Public Health 25, 1853 (2025).","journal-title":"BMC Public Health"},{"key":"1149_CR182","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1016\/j.cgh.2023.03.036","volume":"21","author":"PS Liang","year":"2023","unstructured":"Liang, P. S. et al. Blood test increases colorectal cancer screening in persons who declined colonoscopy and fecal immunochemical test: a randomized controlled trial. Clin. Gastroenterol. Hepatol. 21, 2951\u20132957 (2023).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1149_CR183","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S2468-1253(24)00279-6","volume":"9","author":"The Lancet Gastroenterology & Hepatology","year":"2024","unstructured":"The Lancet Gastroenterology & Hepatology. Blood tests for colorectal cancer: practical or premature? Lancet Gastroenterol. Hepatol. 9, 895 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1149_CR184","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cgh.2022.12.006","volume":"21","author":"GM Cavestro","year":"2023","unstructured":"Cavestro, G. M. et al. Delphi initiative for early-onset colorectal cancer (DIRECt) international management guidelines. Clin. Gastroenterol. Hepatol. 21, 581\u2013603 (2023).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1149_CR185","doi-asserted-by":"publisher","first-page":"oyaf199","DOI":"10.1093\/oncolo\/oyaf199","volume":"30","author":"K Ng","year":"2025","unstructured":"Ng, K. et al. A blueprint for creating an early-onset colorectal cancer program based on experiences from 7 clinical centers across the United States and Canada. Oncologist 30, oyaf199 (2025).","journal-title":"Oncologist"},{"key":"1149_CR186","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0029","volume":"22","author":"AB Benson","year":"2024","unstructured":"Benson, A. B. et al. Colon cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J. Natl Compr. Canc. Netw. 22, e240029 (2024).","journal-title":"J. Natl Compr. Canc. Netw."},{"key":"1149_CR187","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/jamasurg.2014.3572","volume":"150","author":"PJ Kneuertz","year":"2015","unstructured":"Kneuertz, P. J. et al. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA Surg. 150, 402\u2013409 (2015).","journal-title":"JAMA Surg."},{"key":"1149_CR188","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3390\/cancers11101558","volume":"11","author":"A Georgiou","year":"2019","unstructured":"Georgiou, A. et al. Outcomes of patients with early onset colorectal cancer treated in a UK specialist cancer center. Cancers 11, 1558 (2019).","journal-title":"Cancers"},{"key":"1149_CR189","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/bjs.11526","volume":"107","author":"AM Zaborowski","year":"2020","unstructured":"Zaborowski, A. M. et al. Clinicopathological features and oncological outcomes of patients with young-onset rectal cancer. Br. J. Surg. 107, 606\u2013612 (2020).","journal-title":"Br. J. Surg."},{"key":"1149_CR190","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1200\/JCO.2010.33.5281","volume":"29","author":"CD Blanke","year":"2011","unstructured":"Blanke, C. D. et al. Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials. J. Clin. Oncol. 29, 2781\u20132786 (2011).","journal-title":"J. Clin. Oncol."},{"key":"1149_CR191","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1245\/s10434-007-9465-x","volume":"14","author":"HM Quah","year":"2007","unstructured":"Quah, H. M. et al. Young age influences treatment but not outcome of colon cancer. Ann. Surg. Oncol. 14, 2759\u20132765 (2007).","journal-title":"Ann. Surg. Oncol."},{"key":"1149_CR192","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/jamasurg.2016.5050","volume":"152","author":"J Manjelievskaia","year":"2017","unstructured":"Manjelievskaia, J. et al. Chemotherapy use and survival among young and middle-aged patients with colon cancer. JAMA Surg. 152, 452\u2013459 (2017).","journal-title":"JAMA Surg."},{"key":"1149_CR193","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1200\/JCO.21.02008","volume":"39","author":"E Fontana","year":"2021","unstructured":"Fontana, E. et al. Early-onset colorectal adenocarcinoma in the IDEA database: treatment adherence, toxicities, and outcomes with 3 and 6 months of adjuvant fluoropyrimidine and oxaliplatin. J. Clin. Oncol. 39, 4009\u20134019 (2021).","journal-title":"J. Clin. Oncol."},{"key":"1149_CR194","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1016\/S1470-2045(21)00588-X","volume":"23","author":"C Eng","year":"2022","unstructured":"Eng, C. et al. A comprehensive framework for early-onset colorectal cancer research. Lancet Oncol. 23, e116\u2013e128 (2022).","journal-title":"Lancet Oncol."},{"key":"1149_CR195","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-011258","volume":"13","author":"J Dent","year":"2025","unstructured":"Dent, J. et al. Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee. J. Immunother. Cancer 13, e011258 (2025).","journal-title":"J. Immunother. Cancer"},{"key":"1149_CR196","doi-asserted-by":"publisher","first-page":"djv005","DOI":"10.1093\/jnci\/djv005","volume":"107","author":"A Barzi","year":"2015","unstructured":"Barzi, A., Sadeghi, S., Kattan, M. W. & Meropol, N. J. Comparative effectiveness of screening strategies for Lynch syndrome. J. Natl Cancer Inst. 107, djv005 (2015).","journal-title":"J. Natl Cancer Inst."},{"key":"1149_CR197","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10689-024-00422-y","volume":"23","author":"MA Bissmeyer","year":"2024","unstructured":"Bissmeyer, M. A., Velarde, A., Salazar, A. S. & Zamorano, A. S. Use and feasibility of a Lynch syndrome predictive model for inherited colorectal and endometrial cancer in a low-middle income country. Fam. Cancer 23, 563\u2013567 (2024).","journal-title":"Fam. Cancer"},{"key":"1149_CR198","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.cgh.2024.12.026","volume":"23","author":"AV Campos-Segura","year":"2025","unstructured":"Campos-Segura, A. V. et al. Characterization of screening strategies for Lynch syndrome in Latin America. Clin. Gastroenterol. Hepatol. 23, 1642\u20131654 (2025).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1149_CR199","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"A Afshin","year":"2017","unstructured":"Afshin A. et al. Health effects of overweight and obesity in 195 countries over 25 years. N. Engl. J. Med. 377, 13\u201327 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1149_CR200","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-publhealth-040218-043657","volume":"41","author":"JF Sallis","year":"2020","unstructured":"Sallis, J. F. et al. Built environment, physical activity, and obesity: findings from the International Physical Activity and Environment Network (IPEN) adult study. Annu. Rev. Public Health 41, 119\u2013139 (2020).","journal-title":"Annu. Rev. Public Health"},{"key":"1149_CR201","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1016\/S0140-6736(16)30066-6","volume":"388","author":"B Giles-Corti","year":"2016","unstructured":"Giles-Corti, B. et al. City planning and population health: a global challenge. Lancet 388, 2912\u20132924 (2016).","journal-title":"Lancet"},{"key":"1149_CR202","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/obr.12269","volume":"16","author":"SL Mayne","year":"2015","unstructured":"Mayne, S. L., Auchincloss, A. H. & Michael, Y. L. Impact of policy and built environment changes on obesity-related outcomes: a systematic review of naturally occurring experiments. Obes. Rev. 16, 362\u2013375 (2015).","journal-title":"Obes. Rev."},{"key":"1149_CR203","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3968-z","volume":"18","author":"MJ Gu","year":"2018","unstructured":"Gu, M. J. et al. Attributable causes of colorectal cancer in China. BMC Cancer 18, 38 (2018).","journal-title":"BMC Cancer"},{"key":"1149_CR204","first-page":"565","volume":"10","author":"SP Nayak","year":"2009","unstructured":"Nayak, S. P., Sasi, M. P., Sreejayan, M. P. & Mandal, S. A case-control study of roles of diet in colorectal carcinoma in a South Indian Population. Asian Pac. J. Cancer Prev. 10, 565\u2013568 (2009).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"1149_CR205","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/ijc.21438","volume":"118","author":"J Wang","year":"2006","unstructured":"Wang, J. et al. Associations between 5,10-methylenetetrahydrofolate reductase codon 677 and 1298 genetic polymorphisms and environmental factors with reference to susceptibility to colorectal cancer: a case-control study in an Indian population. Int. J. Cancer 118, 991\u2013997 (2006).","journal-title":"Int. J. Cancer"},{"key":"1149_CR206","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41586-020-2859-7","volume":"586","author":"A Choudhury","year":"2020","unstructured":"Choudhury, A. et al. High-depth African genomes inform human migration and health. Nature 586, 741\u2013748 (2020).","journal-title":"Nature"},{"key":"1149_CR207","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s43018-023-00568-1","volume":"4","author":"R Dutta","year":"2023","unstructured":"Dutta, R., Vallurupalli, M., McVeigh, Q., Huang, F. W. & Rebbeck, T. R. Understanding inequities in precision oncology diagnostics. Nat. Cancer 4, 787\u2013794 (2023).","journal-title":"Nat. Cancer"},{"key":"1149_CR208","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/01635580802395733","volume":"61","author":"M Huncharek","year":"2009","unstructured":"Huncharek, M., Muscat, J. & Kupelnick, B. Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr. Cancer 61, 47\u201369 (2009).","journal-title":"Nutr. Cancer"},{"key":"1149_CR209","unstructured":"International Agency for Research on Cancer. Data Visualization Tools for Exploring the Global Cancer Burden in 2024. https:\/\/gco.iarc.who.int\/today\/ (2026)."},{"key":"1149_CR210","unstructured":"United Nations. Human Development Index. https:\/\/hdr.undp.org\/data-center\/human-development-index (2026)."}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01149-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01149-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01149-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:01:01Z","timestamp":1784721661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01149-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":210,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1038\/s41571-026-01149-8","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"9 April 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the past 36 months, A.P. has held equity in Cadex, Khora, OneCell, Parithera and XGenomes; has been an adviser and\/or consultant for 3T Biosciences, AbbVie, Adroya, Amgen, AstraZeneca, Bristol Myers Squibb, CVS, CareSet, Caris, Delicate, DoMore Diagnostics, Eli Lilly, Exact Sciences, Foundation Medicine, GSK, Guardant, Hookipa, Incyte, Johnson & Johnson, Kahr, Merck, Mirati, MPM Capital, Naterara, Neogenomics, Pfizer, Pheon, Phesi, PMV Pharma, Regeneron, Science For America, Seagen, Sirtex, Summit Therapeutics, Takeda, Third Rock Ventures, Value Analytics Labs, Xilio and Zola; is Chief Scientist of Reversing Early Recurrence; receives author fees from Up to Date; has received travel fees from Karkinos Healthcare; and\u00a0works in an institution that has received research funding from Bristol Myers Squibb, Daiichi Sankyo, Eli Lilly, Erasca, Genentech, Incendia, Mirati, Pheon, PMV Pharma, Revolution Medicine, Syndax and Xilio. Y.C. has been a consultant for Bayer Need for unrelated work. A.T.C. has been a paid consultant for Boehringer Ingelheim and Pfizer for work unrelated to this article and receives grant support from Freenome for work unrelated to this article. D.J.L. and B.S. declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}